jeremiah@devisedesigns.com, Author at Corcept Therapeutics

This author has not written his bio yet.
But we are proud to say that jeremiah@devisedesigns.com contributed 151 entries already.

Miricorilant, a selective GR modulator, induced a rapid and significant reduction in liver fat content in a randomized, placebo-controlled phase 2a study in patients with nonalcoholic steatohepatitis

Kowdley et al • 2021 • The Liver Meeting 2021 (American Association for the Study of Liver Diseases)

January 28, 2023

Lorusso et al. • 2021 • European Society for Medical Oncology (ESMO) Congress 2021

January 27, 2023

Greenstein et al. • 2021 • Oncotarget . 2021 Jun 22;12(13):1243-1255. doi: 10.18632/oncotarget.27989.

January 26, 2023

Greenstein et al. • 2021 • Endocr Relat Cancer . 2021 Jun 29;28(8):583-592. doi: 10.1530/ERC-21-0048.

January 25, 2023

Hunt et al • 2021 • Journal of Clinical Psychopharmacology: August 6, 2021

January 24, 2023

• •

January 13, 2023

Isaac Sachmechi, MD, FACE, FACP; Sanna Salam; Muhammad Umair, MD; Kathleen Wade Tarnowski, MSc • 2021 •

November 25, 2022

Albert W. Coo, MD, FACE; Rebecca Ray, FNP-C • 2021 •

November 24, 2022

Greenstein et al. • 2020 • AACR Annual Meeting 2020

November 22, 2022

Greenstein et al. • 2020 • Citation: J Clin Oncol 38: 2020 (suppl; abstract #: 3091)

November 20, 2022